Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer early ...
The test involves using a dedicated chip and fluorescence analysis, in which fragments of cell-free DNA in the blood are ...
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes ...
A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and ...
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...
Patterns of Response to Immune Checkpoint Inhibitors in Sarcomas With High Tumor Burden and/or Mismatch Repair Deficiency The Shield test is a blood-based assay that uses multimodal analysis of ...
When a tumor starts to grow in the body, small bits of its genetic material may break away and float off into the bloodstream. This so-called cell free DNA can be used to identify cancer at very early ...
Major technological advances have been made in imaging, especially in the quality of the resolution or detail.
Speed is a critical differentiator in therapeutic development. For teams developing DNA and RNA therapeutics, non-viral gene therapies, viral vectors, cell-free protein synthesis workflows, or CRISPR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results